Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 12, 2022 | Post-IPO Debt | $125M | 1 | OrbiMed | — | Detail |
Mar 24, 2022 | Post-IPO Equity | — | 1 | ARK Investment Management | — | Detail |
Jul 14, 2020 | Post-IPO Equity | — | — | — | — | Detail |
Jun 26, 2019 | IPO | $300M | — | — | — | Detail |
Mar 5, 2018 | Secondary Market | — | 1 | — | — | Detail |
May 7, 2015 | Series F | $195M | 4 | Matrix Capital Management | — | Detail |
Jan 7, 2015 | Series E | $94M | — | — | — | Detail |
Apr 15, 2014 | Series D | $100M | 1 | Viking Global Investors | — | Detail |
Apr 7, 2014 | Series C | $5M | 1 | Viking Global Investors | — | Detail |
Sep 13, 2013 | Grant | $2.50M | — | — | — | Detail |
Jun 10, 2011 | Series B | $5.80M | — | — | — | Detail |
Mar 24, 2010 | Series A | $4.55M | — | — | — | Detail |